Ernexa Therapeutics Inc. Stock Issued During Period, Shares, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Ernexa Therapeutics Inc. stock issued during period, shares, other for fiscal 2016 was 18.00K shares, a 4900.00% increase from fiscal 2015.
- Ernexa Therapeutics Inc. stock issued during period, shares, other for fiscal 2015 was 360.00 shares, a 99.16% decline from fiscal 2014.
- Ernexa Therapeutics Inc. stock issued during period, shares, other for fiscal 2014 was 43.00K shares.
| Period end | Stock Issued During Period, Shares, Other 3 month | Stock Issued During Period, Shares, Other 12 month |
|---|---|---|
| 2016-12-31 | 18.00K shares 10-K · filed 2017-03-09 | |
| 2015-12-31 | 360.00 shares 10-K · filed 2017-03-09 | |
| 2014-12-31 | 43.00K shares 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |